Targeted Nanoparticle Delivery of Therapeutic Antisense microRNAs Presensitizes Glioblastoma Cells to Lower Effective Doses of Temozolomide in Vitro and in a Mouse Model
Oncotarget - United States
doi 10.18632/oncotarget.25135
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 4, 2018
Authors
Publisher
Impact Journals, LLC